These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3946177)

  • 1. Bioavailability and elimination of digitoxin in patients with hepatorenal insufficiency.
    Kirch W; Ohnhaus EE; Dylewicz P; Pabst J; Storstein L
    Am Heart J; 1986 Feb; 111(2):325-9. PubMed ID: 3946177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digitoxin in patients with hepatorenal insufficiency after repeated oral administration.
    Kirch W; Ohnhaus EE; Pabst J; Storstein L
    Eur Heart J; 1989 Jan; 10(1):40-7. PubMed ID: 2702965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioavailability of digitoxin by a specific assay.
    MacFarland RT; Marcus FI; Fenster PE; Graves PE; Perrier D
    Eur J Clin Pharmacol; 1984; 27(1):85-9. PubMed ID: 6489430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digitoxin and its metabolites in patients with liver cirrhosis.
    Nokhodian A; Santos SR; Kirch W
    Eur J Drug Metab Pharmacokinet; 1993; 18(2):207-13. PubMed ID: 8243505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin.
    Keller F; Kreutz G; Vöhringer HF; Offermann G; Distler A
    Clin Pharmacokinet; 1985; 10(6):514-23. PubMed ID: 4064450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of verapamil, diltiazem, and nifedipine on plasma levels and renal excretion of digitoxin.
    Kuhlmann J
    Clin Pharmacol Ther; 1985 Dec; 38(6):667-73. PubMed ID: 3905167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in normal subjects.
    Graves PE; Fenster PE; MacFarland RT; Marcus FI; Perrier D
    Clin Pharmacol Ther; 1984 Nov; 36(5):601-6. PubMed ID: 6488680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency.
    Graves PE; Fenster PE; MacFarland RT; Marcus FI; Perrier D
    Clin Pharmacol Ther; 1984 Nov; 36(5):607-12. PubMed ID: 6488681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitoxin elimination reduced during quinidine therapy.
    Garty M; Sood P; Rollins DE
    Ann Intern Med; 1981 Jan; 94(1):35-7. PubMed ID: 7447220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease.
    Kirch W; Rose I; Demers HG; Leopold G; Pabst J; Ohnhaus EE
    Clin Pharmacokinet; 1987 Aug; 13(2):110-7. PubMed ID: 2887325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Digitoxin in hepatorenal insufficiency].
    Maier C; Kolenda KD
    Dtsch Med Wochenschr; 1983 Sep; 108(39):1475-80. PubMed ID: 6617500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digitoxin kinetics and renal excretion in children.
    Larsen A; Storstein L
    Clin Pharmacol Ther; 1983 Jun; 33(6):717-26. PubMed ID: 6851404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1975 Mar; 17(3):313-20. PubMed ID: 1120397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digitoxin-quinidine interaction: pharmacokinetic evaluation.
    Fenster PE; Powell JR; Graves PE; Conrad KA; Hager WD; Goldman S; Marcus FI
    Ann Intern Med; 1980 Nov; 93(5):698-701. PubMed ID: 7212478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum concentration and excretion of H3Y digitoxin in humans under normal and pathologic conditions].
    Lahrtz H; Reinold HM; van Zwieten PA
    Klin Wochenschr; 1969 Jul; 47(13):695-700. PubMed ID: 5382549
    [No Abstract]   [Full Text] [Related]  

  • 18. Digitoxin accumulation.
    Ochs HR; Pabst J; Greenblatt DJ; Hartlapp J
    Br J Clin Pharmacol; 1982 Aug; 14(2):225-9. PubMed ID: 7104174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
    Lundgren S; Kvinnsland S; Utaaker E; Bakke O; Ueland PM
    Cancer Chemother Pharmacol; 1986; 18(3):270-5. PubMed ID: 2948732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on digitalis. II. The influence of impaired renal function on the renal excretion of digitoxin and its cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1974 Jul; 16(1):25-34. PubMed ID: 4843236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.